Skip to main content

Oral Anticoagulants and/or Aspirin

  • Conference paper

Abstract

Important progress has been made during the past few years in the understanding of putative successes and failures of oral anticoagulation (OAC) in general, and in the secondary prevention of myocardial infarction in particular. Not only did the conception of thrombotic pathogenesis of the transmural type of myocardial infarction revive after successful removal of acute coronary obstruction by the use of streptokinase, a thrombolytic agent (Loeliger 1981); the results of the Dutch Sixty-Plus Reinfarction Study, which showed a significantly better prognosis for patients given continued oral anticoagulant therapy (Sixty-Plus Reinfarction Study Research Group 1980), reopened the discussion about oral anticoagulants in myocardial infarction (Mitchell 1981). It became clear that strict adherence to a well-defined therapeutic range (Poller 1982), therapeutic quality control (Duxbury 1982), and standardization of the prothrombin time (Loeliger and Lewis 1982) were essential for successful anticoagulation; in their absence such treatment is doomed to failure (Loeliger 1981).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Altman R, Boullon F, Raca R, et al. (1976) Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves. J Thorac Cardiovasc Surg 72: 127

    PubMed  CAS  Google Scholar 

  • AMIS Research Group (1980) A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 243: 661

    Article  Google Scholar 

  • Aspenstrøm G, Korsan-Bengtsen K (1964) A double blind study of dicumarol prophylaxis in coronary heart disease. Acta Med Scand 176: 563

    Article  Google Scholar 

  • Baptista J and Pike MC (1977) Exact two-sided confidence limits for the odds ratio in a 2 × 2 table. Applied Stat 26: 214–220

    Article  Google Scholar 

  • Bjerkelund CJ (1957) The effect of long-term treatment with dicoumarol in myocardial infarction. Acta Med Scand 158 [Suppl 330]:

    Google Scholar 

  • Borchgrevink CF (1960) Long-term anticoagulant therapy in angina pectoris and myocardial infarction. Acta Med Scand [Suppl 359]

    Google Scholar 

  • Breddin K, Loew D, Lechner K et al. (1980) Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon. Haemostasis 9: 325

    PubMed  CAS  Google Scholar 

  • British Medical Research Council (1964) An assessment of long-term anticoagulant administration after cardiac infarction. Br Med J 2: 837

    Article  Google Scholar 

  • Clausen J, Andersen PE, Andresen P, et al. (1961) Langtids-antikoagulansbehandling efter akut hjerteinfarkt. Ugeskr Laeger 123: 987

    PubMed  CAS  Google Scholar 

  • Conrad LL, Kyriacopoulos JD, Wiggins CW et al. (1964) Prevention of recurrences of myocardial infarction. Arch Intern Med 114: 348

    PubMed  CAS  Google Scholar 

  • Dale J (1976) Arterial thromboembolic complications in patients with Starr-Edwards aortic ball balve prostheses. Am Heart J 91: 653

    Article  PubMed  CAS  Google Scholar 

  • Dale J (1977) Arterial thromboembolic complications in patients with Bjork-Shiley and Lillehei-Kaster aortic disc valve prostheses. Am Heart J 93: 715

    Article  PubMed  CAS  Google Scholar 

  • Dale J, Myhre E, Storstein O, et al. (1977) Prevention of arterial thromboembolism with acetylalicylic acid. A controlled clinical study in patients with aortic ball valves. Am Heart J 94: 101

    Google Scholar 

  • Duxbury BMcD (1982) Therapeutic control of anticoagulant treatment. Br Med J 284: 702

    Article  CAS  Google Scholar 

  • Ebert RV, Borden CW, Hipp HR et al. (1969) Long-term anticoagulant therapy after myocardial infarction. JAMA 207: 2263

    Article  PubMed  CAS  Google Scholar 

  • EPSIM Research Group (1982) A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction. N Engl J Med 307: 701

    Article  Google Scholar 

  • Harvald B, Hilden T, Lund E (1962) Long-term anticoagulant therapy after myocardial infarction. Lancet 11: 626

    Article  Google Scholar 

  • Loeliger EA (1981) Oral anticoagulation in the secondary prevention of myocardial infarction. Acta Med Scand 210 [Suppl. 651]: 3

    Google Scholar 

  • Loeliger EA (1983) A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction. N Engl J Med 308: 282

    PubMed  CAS  Google Scholar 

  • Loeliger EA, Lewis SM (1982) Progress in laboratory control of oral anticoagulants. Lancet 2: 318

    Article  PubMed  CAS  Google Scholar 

  • Loeliger EA, Hensen A, Kroes F, et al. (1967) A double-blind trial of long-term anticoagulant treatment after myocardial infarction. Acta Med Scand 182: 549

    Article  PubMed  CAS  Google Scholar 

  • Lovell RHH, Denborough MA, Nestel PJ et al. (1967) A controlled trial of long-term treatment with anticoagulants after myocardial infarction in 412 male patients. Med J Aust 2: 97

    PubMed  CAS  Google Scholar 

  • MacMillan RL, Brown KWG, Watt DL (1960) Long-term anticoagulant therapy after myocardial infarction. Can Med Assoc J 83: 567

    PubMed  CAS  Google Scholar 

  • Meuwissen OJAT, Vervoorn AC, Cohen O, et al. (1969) Double-blind trial of long-term anticoagulant treatment after myocardial infarction. Acta Med Scand 186: 361

    Article  PubMed  CAS  Google Scholar 

  • Mitchell JRA (1981) Anticoagulants in coronary heart disease — retrospect and prospect. Lancet 1: 257

    Article  PubMed  CAS  Google Scholar 

  • Poller L (1982) Anticoagulants reassessed. Br Med J 284: 1425

    Article  CAS  Google Scholar 

  • Rozenberg MC, Kronenberg H, Firkin BG (1965) “Thrombotest” and prothrombin time: a controlled clinical trial. Aust Ann Med 14:3

    Google Scholar 

  • Seaman AJ, Griswold HE, Reaume RB et al. (1969) Long-term anticoagulant prophylaxis after myocardial infarction. N Engl J Med 281: 115

    Article  PubMed  CAS  Google Scholar 

  • Sixty-Plus Reinfarction Study Research Group (1980) A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet 2: 989

    Google Scholar 

  • Sixty-Plus Reinfarction Study Research Group (1982) Risks of longterm oral anticoagulant therapy in elderly patients after myocardial infarction Lancet 1: 64

    Google Scholar 

  • Sørensen OH, Friis T, Jorgensen AW, et al. (1969) Anticoagulant treatment of acute coronary thrombosis. Acta Med Scand 185: 65

    Article  PubMed  Google Scholar 

  • Thomas DG and Gart JJ (1977) A table of exact confidence limits for differences and ratios of two proportions and their odds ratio. J Am Stat Assoc 72: 73

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Spriger-Verlag Berlin Heidelberg

About this paper

Cite this paper

Loeliger, E.A. (1983). Oral Anticoagulants and/or Aspirin. In: Roskamm, H. (eds) Prognosis of Coronary Heart Disease Progression of Coronary Arteriosclerosis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69052-5_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-69052-5_26

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-69054-9

  • Online ISBN: 978-3-642-69052-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics